News

Hexoskin @ HITLAB New York City Health Innovation Week

This week Hexoskin was participating in HITLAB's New York City Health Innovation Week in Manhattan. The event was attended by dozens of startups and large life science companies such as Merck, Novo Nordisk, and Sanofi.

To learn more about Hexoskin's involvement in pharma trials and clinical research, please write us at: contact@hexoskin.com

Hexoskin @ 2024 JP Morgan Conference

Hexoskin will be in San Francisco again this year during the 42nd Annual J.P. Morgan Healthcare Conference, the largest life sciences investment event in the world.

We'll take the opportunity to meet with our clients and partners who use the Hexoskin software platform and wearables to advance our knowledge of human physiology.

We'll also present our new Hexoskin OneView platform for research and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.

Contact us to book a meeting: contact@hexoskin.com

Hexoskin @ HITLAB Innovators Summit 2023

This November at the HITLAB Innovators Summit at Columbia University in NYC we officially launched our new Hexoskin OneView platform for clinical research! For a long time we knew there was a need for better software to support digital biomarker development and clinical research with medical wearables.

We understand the needs of research organizations and clinical sites when it comes to onboarding participants, monitoring compliance and data quality.

So we did something about it.

OneView is the best solution for doing clinical research with Hexoskin and Astroskin wearables. It allows you to:

• Manage cohorts and calendars
• Monitor data quality and compliance
• Use study templates, standardized questionnaires and data reports
• Easily clone studies to create new study arms
• Export all data to other systems like R and SAS for biostatistics

The platform also includes a mobile app for patient reported outcomes and participant tasks management.

On top of that, Hexoskin offers turnkey services for clinical trials: protocol planning and design, recruitment, study support, biostatistics and endpoints, etc.

OneView is already used today by a select group of research organizations and Pharma companies - who joined our beta program earlier this year - to run clinical trials with a decentralized or virtual component. Their feedback has been amazing and has helped us improve OneView to make it an essential research tool.

Please visit our website: hexoskin.com/oneview to learn more about digital tools for clinical research.

The recording from the event is available below:

HITLAB Digital Health Summit 2023 - Hexoskin Video

Our CEO Pierre-Alexandre Fournier presented some of Hexoskin's efforts to solve the evidence gap for healthcare and clinical trials at Columbia University last month, and HITLAB recently made the 15 minutes video available online below.

Clinical evidence is what makes medical discoveries possible: that's how we measure safety and efficacy, and that's how we measure efficiency gains in healthcare delivery. When we lower the cost of evidence, we make care more accessible and affordable. This is an important part of our mission at Hexoskin.

In the video you'll see a few examples of our work at Hexoskin, from clinical research to AI development to human spaceflight.

The Hexoskin and Astroskin platform has been used to collect health data for over 200 scientific publications. White papers about wearable sensors applications for health monitoring of are available upon request.

Live Webinar - Join us on May 30, 2018 at 12PM (EST) for a Live Webinar on Respiratory Monitoring!

The Hexoskin Connected Health Platform is used by researchers in many domains all around the world. Remote & Continuous Respiratory Monitoring is a field of interest that is gaining momentum, but few non-invasive solutions exist to monitor the lung function of subjects and patients.

We invite you to our second webinar that will cover our latest results and applications in respiratory research. We will also present how Hexoskin can monitor COPD patients by using its very unique physiological data.

Webinar: Remote & Continuous Respiratory Monitoring with Hexoskin
30 May 2018, at 12:00 PM (EST) - via the Zoom Video Conferencing software

Speaker: Thu Ngan Trinh, PhD, Clinical Application Specialist at Hexoskin
Guest Speaker: Ruud van Leuteren, MSc, PhD Candidate in Neonatology at the Academic Medical Centre in Amsterdam.

If you are unable to attend, we still invite you to register and we will send you the recorded webinar by email afterward.

We look forward to your presence at this new webinar!

About Hexoskin
Founded in 2006, Hexoskin has designed a system to minimize user setup time and to maximize vital signs monitoring over long periods in a non-obstructive way with sensors embedded in a Smart Shirt. Data are synced to local and remote servers for health data management and analysis. Hexoskin offers a non-invasive solution for longitudinal studies in cardiology, respiratory, sleep, CNS, activity, stress and mental illness. 

Meet us at BIO in Boston on June 4-8, 2018!

Hexoskin will be attending the BIO International Convention in Boston, June 4-7, 2018 for its second year! The Smart Clothing industry's leader will present its new clinically validated collection of Smart Garments for clinical research. Hexoskin will also showcase the Hexoskin Smart, the best health monitor for continuous cardiac, respiratory, activity and sleep tracking. Hexoskin will also unveil a new solution to manage clinical trials and report real-world evidence with Machine Learning & AI. Come meet us!

Fierce Pharma: Pharma has a real-world problem, and it's the lag in its sensor adoption

Adoption of mobile and connected health tech in clinical trials is a real-world challenge for pharmaceutical companies. Our CEO Pierre-Alexandre Fournier has shared his thoughts recently about the adoption of mobile and connected health tech with Fierce Pharma.

"The industry needs to get with it now or pay for it later—literally. The reason? Sensor tech will be adopted faster at a large scale in healthcare than in pharma trials, and that means “the drugs you are developing today are going to be seen with tools that you are not using in your trials right now.”  That could cost drugmakers billions of dollars if they launch products only to find that monitoring tech turns up real-world outcomes that don’t meet payers’ standards."

Read more on Fierce Pharma.

Hexoskin Demonstrates its Connected Health Platform and Biometric Shirt at BIO 2017 in San Diego

Hexoskin is attending the 2017 BIO conference in San Diego this week, and will be demonstrating its connected health platform and biometric shirt at the Quebec pavilion (booth 4315).

The Hexoskin open-data platform enables the development of new digital markers, third-party device integration, ePROs, artificial intelligence and application-specific development.

In order to meet clinical trial development requirements, Hexoskin works in partnership with pharma and biotechs to design efficient protocols for continuous patient monitoring. Clinical areas of interest include those with a need for longitudinal studies in cardiology, respiratory, sleep, CNS, activity, stress, mental illness, etc. 

The Hexoskin software research platform is designed to generate continuous health data for the development of Artificial Intelligence (machine learning) algorithms for chronic diseases management. Hexoskin also offers AI and data science services to pharma and biotech companies.

Hexoskin demonstrates its connected health platform at DPharm in Boston

This week Hexoskin is in Boston to attend the 3rd Annual Mobile in Clinical Trials on September 19th and the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials on September 20-21, 2016 in Boston. This annual event sponsored by Hexoskin is an opportunity for the Life Science industry to share the latest thinking, insights, and updates on the application of disruptive and mobile technologies to advance clinical research and drug development.

On September 20th, Pierre-Alexandre Fournier, CEO and Co-Founder of Hexoskin will present how clinical grade wearable sensors like Hexoskin is used for long-term remote monitoring in clinical trials. He will also share with the participants some use cases involving Hexoskin for monitoring patients in clinical research, and share lessons learned & best practices.

Additionally, Hexoskin will demonstrate its technology in the exhibition hall of the conference on September 20-21st (booth #35). The Hexoskin team will present how Hexoskin can be used in clinical development with live demos and presentations.

We're very excited to join world-class innovators at DPharm to discuss and reflect on how disruptive technologies like Hexoskin will change the landscape of clinical trials.

If you're in Boston come visit us on September 20-21st!

September 19, 2016: Mobile in Clinical Trials (Boston)

September 20-21, 2016: DPharm (Boston) - Disruptive Innovation to Advance Clinical Trials Conference

About Hexoskin
Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by space and defense agencies, sports scientists, and thousands of health professionals and health researchers all over the world, providing a new, convenient way to understand human health in real-life environments. For more information, visit www.hexoskin.com and @Hexoskin on Twitter.

Hexoskin Partners with Kissei for Distribution in Japan

Tokyo, April 6th 2016

Today Hexoskin and Kissei Comtec have announced a partnership to distribute Hexoskin's biometric clothing and connected health software alongside Kissei's products in the Japanese market. The partnership also involves the integration of Hexoskin data in Kissei's sports science and health research software.

"This partnership with Kissei will help Hexoskin support more sports science and health research projects in Japan", said Pierre-Alexandre Fournier, CEO and co-founder of Hexoskin. "This is part of our plan to expand our activities in clinical and medical applications worldwide."

"The Hexoskin smart shirt has been attracting attention as a supportive technology for personal healthcare in Japan. By fusing the excellent know-how of the sensing technology of Hexsokin and clinical and research know-how of Kissei Comtec, we will develop and provide unique healthcare services for the Japanese market." said Kazuhisa Hanamura, overseas manager for the public sector and medical solutions at Kissei Comtec.

Hexoskin smart shirts are widely recognized as the most sophisticated biometric clothing product on the market today. Its new award-winning Hexoskin Smart has a SDK for mobile developers, providing direct access to Hexoskin's data and an API for cloud-based health and research applications. Users can download complete raw data for analysis and export it to third party software.

Hexoskin works for both iPhone and Android users, and different shirt models are available for men, women, and kids. Hexoskin shirts are odor-resistant, comfortable, and safe to use in various real-life situations from sleeping to contact sports. Hexoskin shirts are also scientifically validated to accurately measure heart rate, breathing, and movement, providing users with insights about their physical training, sleep, and daily activities whether awake or asleep.

About Hexoskin

Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by first responders, sport scientists, and thousands of health professionals and health researchers all over the world, and provide a new, convenient way to understand human health in real-life environments. In addition to serving its clients in sports science and health research, Hexoskin is a supplier of smart clothing for aerospace and military organisations in many countries, including Canada and the United States. For more information, visit www.hexoskin.com and @Hexoskin on Twitter.

About Kissei Comtec

Kissei Comtec is a division of Kissei, a Japanase conglomerate focused on pharmaceutical products and medical devices. Kissei Comtec has created a diverse line-up of original software and systems in the medical field, ranging from biosignal analysis software that has become the standard in medical research, motion analysis systems specialized for waking analysis for use in physical rehabilitation, to systems for general health management and disease prevention.

More information on Hexoskin smart shirts is available in Japanese here: http://www.kicnet.co.jp/medical/biosignal/HEXOSKIN/index.html